Reduced Frequency of Stroke Monitoring Proven Safe and Resource-Efficient in New Study

A groundbreaking study reveals that reducing post-thrombolysis stroke monitoring frequency is safe, effective, and helps optimize healthcare resources, especially in resource-limited settings.
A recent study presented at the 11th European Stroke Organization Conference in Helsinki, Finland, indicates that decreasing the number of vital signs and neurological assessments in low-risk stroke patients after thrombolytic treatment is both safe and advantageous. The research, part of the OPTIMISTmain trial, shows that patients monitored less frequently did not experience worse outcomes, yet the approach significantly eases the burden on nursing staff and frees up intensive care unit (ICU) beds. Led by Professor Craig Anderson from The George Institute for Global Health and UNSW Sydney, along with Professor Victor C. Urrutia from Johns Hopkins University, the study involved 4,515 patients across eight countries, including both high-income and low-middle-income nations.
Traditionally, post-thrombolysis care involves frequent monitoring—initially every 15 minutes and gradually decreasing over 24 hours—based on guidelines established in the 1990s. However, this intensive schedule can strain healthcare resources, especially during times of crisis like the COVID-19 pandemic. Researchers hypothesized that a reduced monitoring protocol might still identify critical issues without compromising patient safety.
In the trial, one group received standard monitoring with 39 assessments over 24 hours, while the other followed a low-intensity protocol with only 19 assessments. Despite the less frequent checks—every four hours after the initial two hours—the results showed comparable rates of adverse outcomes, including death or disability after 90 days, with 31.7% in the low-intensity group and 30.9% in the standard care group. Serious complications such as intracerebral hemorrhage occurred at similar rates (0.2% vs. 0.4%), and overall adverse events remained comparable.
Professor Anderson emphasized that this is the first large-scale study to confirm that less frequent monitoring does not compromise stroke recovery. He noted that the routine hourly checks during the first critical hours are essential, but beyond that, the necessity diminishes. The findings suggest that hospitals worldwide, especially those with limited resources, can adopt low-intensity monitoring protocols, optimizing staffing and bed availability.
Moreover, the implementation of this approach led to a 30% reduction in ICU admissions in participating hospitals. Professor Urrutia highlighted that this strategy is particularly valuable during ongoing healthcare strains, supporting more resilient stroke care systems. As stroke remains a leading cause of death and disability worldwide, innovations like this can significantly impact patient management and healthcare efficiency.
Source: https://medicalxpress.com/news/2025-05-frequent-safe-effective-frees-resources.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Common Lung Cancer Symptom Medication May Reduce Effectiveness of Immunotherapy
New research shows that corticosteroids used to manage lung cancer symptoms may reduce the effectiveness of immunotherapy treatments. Learn how steroid use impacts immune response and patient outcomes.
Combination Therapy Halves Recurrence and Mortality in Stage 3 Colon Cancer
New clinical research shows that adding immunotherapy to chemotherapy after surgery can reduce recurrence and death risk by 50% in stage 3 colon cancer patients, offering hope for more effective, personalized treatments.
Centenarians Show Slower Disease Progression and Fewer Illnesses in Old Age
A groundbreaking study reveals that centenarians experience slower disease development and have fewer illnesses in old age, indicating a unique aging process linked to health resilience.
Breakthrough in Understanding Tick-Borne Bacteria Opens Path for New Treatments
Researchers from the University of Missouri have identified new protein targets in the deadly bacterium Ehrlichia chaffeensis, opening promising avenues for future treatments of tick-borne diseases like ehrlichiosis.